Dec 2022: Uhlelo olusha lokudosa lwangoMsombuluko-ngoLwesithathu-uLwesihlanu lwe-asparaginase erwinia chrysanthemi (i-recombinant)-rywn lugunyazwe i-Food and Drug Administration (Rylaze, Jazz Pharmaceuticals). Iziguli kufanele zithole ama-25 mg/m.
Agasti 2021: I-Food and Drug Administration igunyaze i-asparaginase erwinia chrysanthemi (i-recombinant)-rywn) (i-Rylaze, i-Jazz Pharmaceuticals, Inc.) njengengxenye yohlobo lwemithi ye-chemotherapeutic enama-agent amaningi yokwelashwa kwe-acute lym.